Some Clinical Trial Design Questions and Answers Peter A. Lachenbruch Oregon State University.
Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation.
1 The FDA Approval Process Evidence to Support the Adoption of New Biomarkers Diagnostic Course, Queen’s College, Oxford September 2014 Sally A. Hojvat,
